Ocular Therapeutix Earnings: Turnaround Moment? episode artwork

EPISODE · May 4, 2026 · 1 MIN

Ocular Therapeutix Earnings: Turnaround Moment?

from The Daily News Now! Business

Ocular Therapeutix, OCUL, releases earnings Tuesday, aiming to reverse a sales slump. Analysts predict a 20.8% Y/Y revenue surge, but the company has a history of missing targets. Peers like Eli Lilly and Merck outperformed, driving share gains. OCUL surged 16.5% last month, with a $26 price target looming. A turnaround could boost this hot sectors stock. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/921c39ff9d746ae6

NOW PLAYING

Ocular Therapeutix Earnings: Turnaround Moment?

0:00 1:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 4, 2026.

What is this episode about?

Ocular Therapeutix, OCUL, releases earnings Tuesday, aiming to reverse a sales slump. Analysts predict a 20.8% Y/Y revenue surge, but the company has a history of missing targets. Peers like Eli Lilly and Merck outperformed, driving share...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!